Trial Profile
Kidney Graft Function Under the Immunosuppression Strategies With Low Dose of Neoral(R)(Cyclosporine) and Standard Dose of Myfortic(R)(Enteric-Coated Mycophenolate Sodium) vs. With Conventional Dose of Neoral(R)(Cyclosporine) and Reduced Dose of Myfortic(R)(Enteric-Coated Mycophenolate Sodium) in De Novo Renal Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Ciclosporin
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms MyLowCsA
- 05 Apr 2013 New trial record